1. Home
  2. COCP vs HTCR Comparison

COCP vs HTCR Comparison

Compare COCP & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • HTCR
  • Stock Information
  • Founded
  • COCP 2006
  • HTCR 2009
  • Country
  • COCP United States
  • HTCR Japan
  • Employees
  • COCP N/A
  • HTCR N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • HTCR EDP Services
  • Sector
  • COCP Health Care
  • HTCR Technology
  • Exchange
  • COCP Nasdaq
  • HTCR Nasdaq
  • Market Cap
  • COCP 15.7M
  • HTCR 12.8M
  • IPO Year
  • COCP N/A
  • HTCR 2022
  • Fundamental
  • Price
  • COCP $1.49
  • HTCR $0.52
  • Analyst Decision
  • COCP Strong Buy
  • HTCR
  • Analyst Count
  • COCP 1
  • HTCR 0
  • Target Price
  • COCP $6.00
  • HTCR N/A
  • AVG Volume (30 Days)
  • COCP 26.0K
  • HTCR 194.5K
  • Earning Date
  • COCP 08-13-2025
  • HTCR 08-13-2025
  • Dividend Yield
  • COCP N/A
  • HTCR 3.92%
  • EPS Growth
  • COCP N/A
  • HTCR N/A
  • EPS
  • COCP N/A
  • HTCR N/A
  • Revenue
  • COCP N/A
  • HTCR $28,947,523.00
  • Revenue This Year
  • COCP N/A
  • HTCR N/A
  • Revenue Next Year
  • COCP N/A
  • HTCR $8.59
  • P/E Ratio
  • COCP N/A
  • HTCR N/A
  • Revenue Growth
  • COCP N/A
  • HTCR 59.42
  • 52 Week Low
  • COCP $1.12
  • HTCR $0.49
  • 52 Week High
  • COCP $3.26
  • HTCR $3.38
  • Technical
  • Relative Strength Index (RSI)
  • COCP 45.80
  • HTCR 44.82
  • Support Level
  • COCP $1.48
  • HTCR $0.54
  • Resistance Level
  • COCP $1.58
  • HTCR $0.55
  • Average True Range (ATR)
  • COCP 0.10
  • HTCR 0.03
  • MACD
  • COCP -0.01
  • HTCR 0.00
  • Stochastic Oscillator
  • COCP 15.38
  • HTCR 44.83

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

Share on Social Networks: